Transgenic Animals Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Transgenic Animals Market 

5.1. COVID-19 Landscape: Transgenic Animals Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Transgenic Animals Market, By Transgenic Animals

8.1. Transgenic Animals Market Revenue and Volume Forecast, by Transgenic Animals

8.1.1. Mice

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Rats

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Rabbits

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Sheep

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Goats

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Pigs

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Cattle

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Others (zebrafish, chickens, etc.)

8.1.8.1. Market Revenue and Volume Forecast

Chapter 9. Global Transgenic Animals Market, By Technology

9.1. Transgenic Animals Market Revenue and Volume Forecast, by Technology

9.1.1. CRISPR-Cas9

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. TALENs (Transcription Activator-Like Effector Nucleases)

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Zinc Finger Nucleases (ZFNs)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Microinjection

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Nuclear Transfer (Cloning)

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Transgenic Animals Market, By Application / Use Case

10.1. Transgenic Animals Market Revenue and Volume Forecast, by Application / Use Case

10.1.1. Biomedical Research & Gene Function Studies

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Drug Discovery & Development

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Toxicology & Safety Testing

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Production of Therapeutic Proteins (Pharming)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Xenotransplantation Research

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Agricultural Improvements (growth traits, disease resistance)

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Others

10.1.7.1. Market Revenue and Volume Forecast

Chapter 11. Global Transgenic Animals Market, By End User

11.1. Transgenic Animals Market Revenue and Volume Forecast, by End User

11.1.1. Biotechnology & Pharmaceutical Companies

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Academic & Research Institutes

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Contract Research Organizations (CROs)

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Veterinary Research Centers

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Agricultural Research Bodies

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Transgenic Animals Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.1.2. Market Revenue and Volume Forecast, by Technology

12.1.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.1.4. Market Revenue and Volume Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.1.5.2. Market Revenue and Volume Forecast, by Technology

12.1.5.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.1.5.4. Market Revenue and Volume Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.1.6.2. Market Revenue and Volume Forecast, by Technology

12.1.6.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.1.6.4. Market Revenue and Volume Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.2.2. Market Revenue and Volume Forecast, by Technology

12.2.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.2.4. Market Revenue and Volume Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.2.5.2. Market Revenue and Volume Forecast, by Technology

12.2.5.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.2.5.4. Market Revenue and Volume Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.2.6.2. Market Revenue and Volume Forecast, by Technology

12.2.6.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.2.6.4. Market Revenue and Volume Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.2.7.2. Market Revenue and Volume Forecast, by Technology

12.2.7.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.2.7.4. Market Revenue and Volume Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.2.8.2. Market Revenue and Volume Forecast, by Technology

12.2.8.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.2.8.4. Market Revenue and Volume Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.3.2. Market Revenue and Volume Forecast, by Technology

12.3.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.3.4. Market Revenue and Volume Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.3.5.2. Market Revenue and Volume Forecast, by Technology

12.3.5.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.3.5.4. Market Revenue and Volume Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.3.6.2. Market Revenue and Volume Forecast, by Technology

12.3.6.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.3.6.4. Market Revenue and Volume Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.3.7.2. Market Revenue and Volume Forecast, by Technology

12.3.7.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.3.7.4. Market Revenue and Volume Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.3.8.2. Market Revenue and Volume Forecast, by Technology

12.3.8.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.3.8.4. Market Revenue and Volume Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.4.2. Market Revenue and Volume Forecast, by Technology

12.4.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.4.4. Market Revenue and Volume Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.4.5.2. Market Revenue and Volume Forecast, by Technology

12.4.5.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.4.5.4. Market Revenue and Volume Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.4.6.2. Market Revenue and Volume Forecast, by Technology

12.4.6.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.4.6.4. Market Revenue and Volume Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.4.7.2. Market Revenue and Volume Forecast, by Technology

12.4.7.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.4.7.4. Market Revenue and Volume Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.4.8.2. Market Revenue and Volume Forecast, by Technology

12.4.8.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.4.8.4. Market Revenue and Volume Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.5.2. Market Revenue and Volume Forecast, by Technology

12.5.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.5.4. Market Revenue and Volume Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.5.5.2. Market Revenue and Volume Forecast, by Technology

12.5.5.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.5.5.4. Market Revenue and Volume Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Transgenic Animals

12.5.6.2. Market Revenue and Volume Forecast, by Technology

12.5.6.3. Market Revenue and Volume Forecast, by Application / Use Case  

12.5.6.4. Market Revenue and Volume Forecast, by End User

Chapter 13. Company Profiles

13.1. Novozymes A/S

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial PerTransgenic Animalsance

13.1.4. Recent Initiatives

13.2. DuPont de Nemours, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial PerTransgenic Animalsance

13.2.4. Recent Initiatives

13.3. DSM-Firmenich

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial PerTransgenic Animalsance

13.3.4. Recent Initiatives

13.4. Codexis, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial PerTransgenic Animalsance

13.4.4. Recent Initiatives

13.5. AB Enzymes GmbH

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial PerTransgenic Animalsance

13.5.4. Recent Initiatives

13.6. Amano Enzyme Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial PerTransgenic Animalsance

13.6.4. Recent Initiatives

13.7. BASF SE

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial PerTransgenic Animalsance

13.7.4. Recent Initiatives

13.8. Thermo Fisher Scientific Inc

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial PerTransgenic Animalsance

13.8.4. Recent Initiatives

13.9. Chr. Hansen Holding A/S

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial PerTransgenic Animalsance

13.9.4. Recent Initiatives

13.10. Dyadic International, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial PerTransgenic Animalsance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms